Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2014) | Total Docs. (3years) | Total Refs. (2014) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2014) | %Female (2014) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Theranostics | journal | 1.955 Q1 | 158 | 97 | 200 | 6416 | 1627 | 181 | 8.14 | 66.14 | 33.38 |  |
| 2 | International Journal of Nanomedicine | journal | 1.306 Q1 | 179 | 491 | 1274 | 20697 | 6757 | 1259 | 4.97 | 42.15 | 39.34 |  |
| 3 | Diabetes, Metabolic Syndrome and Obesity | journal | 1.149 Q1 | 64 | 60 | 108 | 3598 | 404 | 105 | 3.74 | 59.97 | 35.27 | |
| 4 | Nanotechnology, Science and Applications | journal | 1.131 Q1 | 35 | 6 | 18 | 604 | 116 | 18 | 7.63 | 100.67 | 14.29 | |
| 5 | Drug Design, Development and Therapy | journal | 1.034 Q1 | 94 | 235 | 227 | 10969 | 872 | 227 | 3.52 | 46.68 | 37.12 | |
| 6 | Core Evidence (discontinued) | journal | 0.983 Q2 | 29 | 13 | 26 | 713 | 105 | 26 | 4.21 | 54.85 | 43.75 | |
| 7 | Biomarker Insights | journal | 0.937 Q2 | 40 | 13 | 49 | 424 | 133 | 49 | 2.72 | 32.62 | 35.90 | |
| 8 | Pharmacogenomics and Personalized Medicine | journal | 0.901 Q2 | 37 | 36 | 38 | 2605 | 124 | 38 | 3.41 | 72.36 | 47.15 | |
| 9 | Infection and Drug Resistance | journal | 0.777 Q2 | 65 | 35 | 71 | 2165 | 171 | 70 | 2.28 | 61.86 | 35.38 | |
| 10 | Drug, Healthcare and Patient Safety | journal | 0.733 Q2 | 30 | 24 | 58 | 1267 | 95 | 52 | 1.60 | 52.79 | 47.22 | |
| 11 | Patient Preference and Adherence | journal | 0.695 Q1 | 67 | 176 | 284 | 6644 | 657 | 281 | 2.28 | 37.75 | 48.28 | |
| 12 | Fluoride - Quarterly Reports | journal | 0.298 Q3 | 51 | 42 | 112 | 1200 | 71 | 102 | 0.68 | 28.57 | 48.48 | |
| 13 | Open Access Journal of Clinical Trials | journal | 0.201 Q3 | 15 | 7 | 42 | 411 | 21 | 38 | 0.53 | 58.71 | 60.71 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data